So far, the company's commercialized drugs have delivered billions of dollars in revenue. For example, in the latest quarter, ...

Over half of CEOs globally are experimenting with AI to generate text, images and other forms of data, a recent joint survey by Fortune and Deloitte found. Meanwhile, a third of organizations are ...

Vertex Pharmaceuticals Incorporated remains a buy despite recent share price weakness, supported by its dominant cystic fibrosis franchise and robust late-stage pipeline. Alyftrek's launch extends ...